Valerie Weaver's team discovers why stiff tissue is a risk factor for breast cancer: it spurs immune cells to release DNA-damaging chemicals, which cause the mutations that ultimately lead to cancer.
Andrew Ko, who led UCSF's trials of daraxonrasib based on discovery science, tells what to know about the medicine, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results